Welcome to LookChem.com Sign In|Join Free
  • or
2-(4-CHLOROPHENYL)-1,3,4-OXADIAZOLE, with the molecular formula C8H5ClN2O, is a chemical compound that falls under the category of phenyl-1,3,4-oxadiazoles. It is a derivative of 1,3,4-oxadiazole featuring a phenyl group attached at the 2-position. 2-(4-CHLOROPHENYL)-1,3,4-OXADIAZOLE is recognized for its distinctive chemical structure, which endows it with potential applications in both pharmaceuticals and materials science. It serves as a valuable building block in the synthesis of biologically active molecules and has been the subject of research for its medicinal properties. Furthermore, it holds promise in the creation of new materials and polymers with tailored characteristics.

23289-10-3

Post Buying Request

23289-10-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23289-10-3 Usage

Uses

Used in Pharmaceutical Industry:
2-(4-CHLOROPHENYL)-1,3,4-OXADIAZOLE is used as a building block for the synthesis of biologically active molecules due to its unique chemical structure. It contributes to the development of new pharmaceutical agents with potential medicinal properties, making it a key component in drug discovery and design.
Used in Materials Science:
In the field of materials science, 2-(4-CHLOROPHENYL)-1,3,4-OXADIAZOLE is utilized in the development of new materials and polymers with specific properties. Its incorporation into these materials can lead to the creation of advanced polymers with tailored characteristics for various applications, showcasing its versatility and potential in material innovation.

Check Digit Verification of cas no

The CAS Registry Mumber 23289-10-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,2,8 and 9 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 23289-10:
(7*2)+(6*3)+(5*2)+(4*8)+(3*9)+(2*1)+(1*0)=103
103 % 10 = 3
So 23289-10-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H5ClN2O/c9-7-3-1-6(2-4-7)8-11-10-5-12-8/h1-5H

23289-10-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(4-Chlorophenyl)-1,3,4-oxadiazole

1.2 Other means of identification

Product number -
Other names 4-chlorophenyl-1,3,4-oxadiazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23289-10-3 SDS

23289-10-3Relevant academic research and scientific papers

The reaction of (N-isocyanimino)triphenylphosphorane with benzoic acid derivatives: a novel synthesis of 2-aryl-1,3,4-oxadiazole derivatives

Souldozi, Ali,Ramazani, Ali

, p. 1549 - 1551 (2007)

The reactions of benzoic acid derivatives with (N-isocyanimino)triphenylphosphorane proceed smoothly at room temperature to afford 2-aryl-1,3,4-oxadiazoles in high yields.

Ligand-Enabled Palladium-Catalyzed Through-Space C?H Bond Activation via a Carbopalladation/1,4-Pd Migration/C?H Functionalization Sequence

Chen, Su,Ranjan, Prabhat,Ramkumar, Nagarajan,Van Meervelt, Luc,Van der Eycken, Erik V.,Sharma, Upendra K.

, p. 14075 - 14079 (2020)

We report, herein, a palladium-catalyzed cascade comprising carbopalladation, 1,4-Pd-migration and C(sp2)?C(sp2) bond formation to construct a variety of bis-heterocyclic frameworks in a single operational step. The methodology provi

COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME

-

Paragraph 0258-0261, (2021/01/29)

The present specification provides a compound represented by chemical formula 1 and an organic light emitting device including the same. The compound may improve lifespan characteristics of the organic light emitting device.

[4u202f+u202f1] Cyclization of benzohydrazide and ClCF2COONa towards 1,3,4-oxadiazoles and 1,3,4-oxadiazoles-d5

Li, Xin,Mu, Shiqiang,Song, Qiuling,Wang, Ya

supporting information, (2021/09/20)

A facile synthesis of 1,3,4-oxadiazoles and 1,3,4-oxadiazoles-d5 via [4 + 1] cyclization of ClCF2COONa with non-amine compounds containing amino groups is developed. Of note, this is the first time that halofluorinated compounds are used as C1 synthon to construct deuterated nitrogen-heterocyclic compounds. The current protocol features simple operation, readily accessible raw materials, wide substrate scope and valuable products

COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME

-

Paragraph 0218-0221, (2021/01/29)

The present specification provides a compound represented by chemical formula 1 and an organic light emitting device including the same. The compound may improve lifespan characteristics of the organic light emitting device.

Functionalization of 1,3,4-Oxadiazoles and 1,2,4-Triazoles via Selective Zincation or Magnesiation Using 2,2,6,6-Tetramethylpiperidyl Bases

Schw?rzer, Kuno,Tüllmann, Carl Phillip,Gra?l, Simon,Górski, Bartosz,Brocklehurst, Cara E.,Knochel, Paul

supporting information, p. 1899 - 1902 (2020/03/03)

We report the metalation of the 1,3,4-oxadiazole and 1,2,4-triazole scaffolds via regioselective zincation or magnesiation using the TMP bases (TMP = 2,2,6,6-tetramethylpiperidyl) TMP2Zn·2LiCl, TMP2Zn·2MgCl2·2LiCl, TMPMgCl

Method for constructing 2-(4-chlorphenyl)-1,3,4-oxadiazole in one step by using DMF as carbon source

-

Paragraph 0016, (2019/03/08)

The invention discloses a method for constructing 2-(4-chlorphenyl)-1,3,4-oxadiazole in one step by using DMF (N, N-dimethylformamide) as a carbon source. The method includes taking p-chlorphenyl hydrazide as a reaction raw material, and taking DMF (N, N-

DMF as Methine Source: Copper-Catalyzed Direct Annulation of Hydrazides to 1,3,4-Oxadiazoles

Wang, Shoucai,Wang, Kai,Kong, Xiangfei,Zhang, Shuhua,Jiang, Guangbin,Ji, Fanghua

supporting information, p. 3986 - 3990 (2019/07/31)

An unprecedented Cu-catalyzed direct annulation of hydrazides with N,N-dimethylformamide (DMF) was developed, providing an efficient synthesis of valuable 1,3,4-oxadiazoles. This process features the short reaction time and can be safely conducted on gram scale. The reaction also facilitated the convenient synthesis of 1,3,4-oxadiazole-2(3H)-ones. Moreover, the mechanistic studies suggest that the source of CH is from the N-methyl group of DMF. (Figure presented.).

Synthesis of 1,3,4-Oxadiazoles via Annulation of Hydrazides and Benzene-1,3,5-triyl Triformate under Metal-Free Conditions

Yin, Zhiping,Power, Dennis J.,Wang, Zechao,Stewart, Scott G.,Wu, Xiao-Feng

supporting information, p. 3238 - 3242 (2018/04/24)

A new and efficient method for the synthesis of 1,3,4-oxadiazoles via the annulation of hydrazides with benzene-1,3,5-triyl triformate (TFBen) under metal-free conditions is reported. A broad range of hydrazides were transformed into the corresponding 1,3

From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II)

Aurelio, Luigi,Scullino, Carmen V.,Pitman, Melissa R.,Sexton, Anna,Oliver, Victoria,Davies, Lorena,Rebello, Richard J.,Furic, Luc,Creek, Darren J.,Pitson, Stuart M.,Flynn, Bernard L.

, p. 965 - 984 (2016/02/23)

The sphingosine kinase (SK) inhibitor, SKI-II, has been employed extensively in biological investigations of the role of SK1 and SK2 in disease and has demonstrated impressive anticancer activity in vitro and in vivo. However, interpretations of results u

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 23289-10-3